| Phase 1/22 trials |
|
Phase 1/2
|
NCT05009719 |
Apr 2021 → Apr 2023 |
hematopoietic and lymphoid cell neoplasm |
St. Petersburg State Pavlov Medical University |
Completed
|
No outcome recorded
|
|
Phase 1/2
|
NCT00923910 |
Feb 2008 → Oct 2013 |
acute lymphoblastic leukemia, acute myeloid leukemia, chronic myeloid leukemia, myelodysplastic syndrome |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|
| Phase 22 trials |
|
Phase 2
|
NCT02684162 |
Jun 2016 → Oct 2024 |
acute myeloid leukemia, chronic myelomonocytic leukemia, myelodysplastic syndrome |
M.D. Anderson Cancer Center |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT00031655 |
Sep 2001 → Aug 2006 |
adult acute lymphoblastic leukemia, childhood acute lymphoblastic leukemia |
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium |
Completed
|
No outcome recorded
|
| Phase not applicable2 trials |
| — |
NCT02105116 |
Feb 2014 → Dec 2015 |
acute erythroid leukemia, acute megakaryoblastic leukemia in adult, acute myeloblastic leukemia with maturation, acute myeloblastic leukemia without maturation +8 |
Rutgers, The State University of New Jersey |
Terminated
|
No outcome recorded
|
| — |
NCT00534118 |
Oct 2003 → Jul 2018 |
leukemia, myelodysplastic syndrome, plasma cell neoplasm |
Roswell Park Cancer Institute |
Completed
|
No outcome recorded
|
| Comparator or background therapy2 trials |
|
Phase 1
|
NCT00476177 Background |
Jul 2003 → Aug 2007 |
hematopoietic and lymphoid system neoplasm |
Dana-Farber Cancer Institute |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT00006252 Background |
Feb 2001 → Jan 2007 |
leukemia, lymphoma |
Cancer and Leukemia Group B |
Completed
|
No outcome recorded
|